ICB International Competitors and Similar CompaniesClear all
ICB International's competitors and similar companies include GBT (Global Blood Therapeutics), S1 Biopharma, OTR3 and Sosei Heptares.
 ICB International ICB International (ICBI) is a company that provides disease altering therapies for afflictions of the central nervous system. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  S1 Biopharma S1 Biopharma is a company developing drugs for the treatment of sexual dysfunction in both women and men. |  OTR3 OTR3 is a biotech company that develops therapeutic agents for skin, mucosa, and corneal complications. | ||
Founding Date | Founding Date 2008 | Founding Date 2012 | Founding Date 2008 | Founding Date 2005 | Founding Date 1990 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations New York, US HQ | Locations Paris, FR HQ | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB |
Employees | Employees 11 | Employees 352106% increase | Employees 4 | Employees 23 | Employees 387 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 697 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥29.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥7.3b (FY, 2025) |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income N/A | Net income N/A | Net income (¥12.5b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyS1 Biopharma
HQ
New York, US
Employees
4
S1 Biopharma is a company developing drugs for the treatment of sexual dysfunction in both women and men.
View companyOTR3
HQ
Paris, FR
Employees
23
OTR3 is a biotech company that develops therapeutic agents for skin, mucosa, and corneal complications.
View company
Sosei Heptares
HQ
Tokyo, JP
Employees
387
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View company